An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.
Jaimy Lee
·
2026-06-01
·
via MarketWatch.com - Top Stories
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another dr…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。